CAS RN: 1239478-87-5
5-(Di(adamantan-1-yl)phosphino)-1′,3′,5′-triphenyl-1’H-1,4′-bipyrazole
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250731 |
100mg / 250mg / 1g / 5g |
Out of stock |
8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1239478-87-5
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>97% |
5
In Stock
|
Shenzhen |
Inquiry |
| 1g |
>97% |
5
In Stock
|
Shenzhen |
Inquiry |
1239478-87-5 / bis(1-adamantyl)-[2-(1,3,5-triphenylpyrazol-4-yl)pyrazol-3-yl]phosphane
Standard CAS: 1239478-87-5
Multi CAS: No
Basic Information
CAS
1239478-87-5
Multi CAS
No
Molecular Formula
C44H47N4P
Molecular Weight
662.800000
Exact Mass
662.353835
SMILES
C1C2CC3CC1CC(C2)(C3)P(C4=CC=NN4C5=C(N(N=C5C6=CC=CC=C6)C7=CC=CC=C7)C8=CC=CC=C8)C91CC2CC(C9)CC(C2)C1
InChI
InChI=1S/C44H47N4P/c1-4-10-36(11-5-1)40-42(41(37-12-6-2-7-13-37)47(46-40)38-14-8-3-9-15-38)48-39(16-17-45-48)49(43-24-30-18-31(25-43)20-32(19-30)26-43)44-27-33-21-34(28-44)23-35(22-33)29-44/h1-17,30-35H,18-29H2
InChIKey
IHFBOUNFWVRWAQ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
49
Aromatic heavy atom count
28
Fraction Csp3
0.45
Rotatable bonds
7
H-bond acceptors
4
Molar refractivity
199.92
TPSA
35.64
LogP / Solubility
WLOGP
10.44
MLOGP
9.24
XLogP3
10.4
Consensus LogP
10.03
Log S (ESOL)
-10.49
Class (ESOL)
Insoluble
Log S (Ali)
-12.53
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-13.47
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
0.65
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10